Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Search Results to Slide Tray Search:

"Agency for Healthcare Research and Quality"

Slides: 1–12 of 103
Add to tray Remove from tray

Study Size Planning for Observational Comparative Effectiveness Research

Presentation: Study Size Planning for Observational Comparative Effectiveness Research
Keywords: comparative effectiveness research | observational | study size | background
Add to tray Remove from tray

Clostridium difficile Infections: Diagnosis, Treatment, and Prevention

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: Agency for Healthcare Research and Quality | diagnosis | prevention | treatment | Clostridium difficile
Add to tray Remove from tray

Outline of this CME Activity

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: antibiotic treatment | diagnostic assays | prevention | recurrence | overview
Add to tray Remove from tray

Agency for Healthcare Research and Quality (AHRQ) Comparative Effectiveness Review (CER) Development

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: Agency for Healthcare Research and Quality (AHRQ) | C. difficile Infection (CDI) | systematic review | comparative effectiveness review development
Add to tray Remove from tray

Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Presentation: Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Keywords: acute coronary syndrome | comparative effectiveness review | distal embolization | percutaneous coronary intervention (PCI) | thrombus | Adjunctive devices
Add to tray Remove from tray

Outline of This CME Activity

Presentation: Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Keywords: outline | comparative effectiveness review | adjunctive devices | percutaneous coronary intervention | outcomes | adverse events
Add to tray Remove from tray

Agency for Healthcare Research and Quality (AHRQ) Comparative Effectiveness Review Development

Presentation: Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Keywords: Agency for Healthcare Research and Quality | AHRQ | peer review | research summary | systematic review | comparative effectiveness review
Add to tray Remove from tray

Analgesics for Osteoarthritis—An Update

Presentation: Analgesics for Osteoarthritis—An Update
Keywords: analgesics | comparative effectiveness review | osteoarthritis | systematic review | background
Add to tray Remove from tray

Agency for Healthcare Research and Quality (AHRQ) Comparative Effectiveness Review (CER) Development

Presentation: Analgesics for Osteoarthritis—An Update
Keywords: comparative effectiveness | systematic review | clinical studies
Add to tray Remove from tray

Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults with Hypertension

Presentation: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension
Add to tray Remove from tray

Rationale for Update

Presentation: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension
Keywords: systematic review | comparative effectiveness | ACEI | ARB | hypertension | aliskiren | DRI
Add to tray Remove from tray

Agency for Healthcare Research and Quality (AHRQ) Comparative Effectiveness Review (CER) Development

Presentation: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension
Keywords: Agency for Healthcare Research and Quality (AHRQ) | comparative effectiveness | nomination | systematic review | clinician | consumer
Pages: [1] 2 3 4 5 6 7 8 9 Next
 
 
 
 
www.ahrq.gov AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364